Preclinical pharmacology and pharmacokinetics of the anti-hepatitis virus agent 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil in mice and rats

about

Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression Striking species difference in the contribution of concentrative nucleoside transporter 2 to nucleoside uptake between mouse and rat hepatocytes.

P2860

Q34077927-F8790505-AA58-4566-81B8-FE00F5BC2A17 Q41810930-4B84D1B4-A81B-4258-B8B1-B208C1E7EA0B

P2860

Preclinical pharmacology and pharmacokinetics of the anti-hepatitis virus agent 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil in mice and rats

Item

http://www.wikidata.org/entity/Q35885095

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Preclinical pharmacology and p ...... ranosyluracil in mice and rats

@ast

Preclinical pharmacology and p ...... ranosyluracil in mice and rats

@en

type

Item

label

Preclinical pharmacology and p ...... ranosyluracil in mice and rats

@ast

Preclinical pharmacology and p ...... ranosyluracil in mice and rats

@en

prefLabel

Preclinical pharmacology and p ...... ranosyluracil in mice and rats

@ast

Preclinical pharmacology and p ...... ranosyluracil in mice and rats

@en

P1476

Preclinical pharmacology and p ...... ranosyluracil in mice and rats

@en

P2093

C A Gloff

http://www.w3.org/2001/XMLSchema#string

J Chiang

http://www.w3.org/2001/XMLSchema#string

P Vidal

http://www.w3.org/2001/XMLSchema#string

T C Chou

http://www.w3.org/2001/XMLSchema#string

W P Tong

http://www.w3.org/2001/XMLSchema#string

X B Kong

http://www.w3.org/2001/XMLSchema#string

P2860

Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides

Synthesis and biological effects of 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil.

Physiologically based pharmacokinetic modeling: principles and applications.

Incorporation and metabolism of 2'-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HSV-1)-infected and mock-infected Vero cells.

Inhibition of simian varicella virus infection of monkeys by 1-(2-deoxy-2- fluoro-1-beta-D-arabinofuranosyl)-5-ethyluracil (FEAU) and synergistic effects of combination with human recombinant interferon-beta.

P304

1472-1477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.36.7.1472

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1992-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1510443

http://www.w3.org/2001/XMLSchema#string

P932

191606

http://www.w3.org/2001/XMLSchema#string

Preclinical pharmacology and pharmacokinetics of the anti-hepatitis virus agent 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil in mice and rats

about

P2860

P2860

Preclinical pharmacology and pharmacokinetics of the anti-hepatitis virus agent 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil in mice and rats

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932